Does Kisspeptin-10 Increase Testosterone
A short solo explainer on one 2013 human study of intravenous kisspeptin-10 and luteinizing hormone and testosterone, with the host's caveats and lifestyle suggestions.
Key moments
Tap a moment to play the video from there.
- 0:00Question and study overviewArchibald previews that intravenous kisspeptin-10 more than doubled LH in small human trials and, with longer infusions, raised testosterone. He also explains that kisspeptin-10 is the final 10 amino acids of the full 54-amino-acid sequence.
- 1:07Why kisspeptin is getting attentionHe mentions a Stanford liver study and suggests kisspeptin may be an alternative to hCG-style approaches because of its pulsatile regulation of hormones.
- 1:37The 2013 Imperial College studyHe describes a Clinical Endocrinology paper in which 16 men, 10 healthy and six with type 2 diabetes and low testosterone, received intravenous kisspeptin-10.
- 2:07LH and testosterone numbersHe reports LH rising from 4.7 to 10.7 after a 3 micrograms per kilogram bolus, and testosterone rising from 8.5 to 11.4 nanomoles per liter over an 11-hour infusion.
- 2:38Activating the axis, not bypassing itArchibald says kisspeptin stimulates GnRH neurons rather than supplying testosterone, and that healthy men showed similar rises in LH pulses and testosterone.
- 3:39Top of the HPG axisHe describes kisspeptin working upstream to drive GnRH, LH and FSH, and argues it preserves rhythmic LH release unlike exogenous testosterone.
- 4:40Research limits and availabilityHe stresses the small, short, intravenous design and says there are no long-term randomized trials or large safety data sets, and no approved product for this use. He recommends a licensed provider and 503A compounding pharmacies.
- 5:41Why is testosterone low?Archibald argues readers should ask the underlying cause first, then describes a camping and wood-cutting study and other lifestyle steps he favors.
What the video says
Regan Archibald asks whether kisspeptin-10, the last 10 amino acids of the 54-amino-acid kisspeptin protein, can raise testosterone without supplying the hormone directly. He frames it as a possible alternative to approaches built on hCG, and notes that the compound has drawn attention for a separate small liver study he attributes to Stanford.
The core of the video is a 2013 study from Imperial College London, published in Clinical Endocrinology. Archibald says it gave intravenous kisspeptin-10 to 16 men, 10 healthy and six with type 2 diabetes and low testosterone. In the diabetic group, he reports that a bolus of 3 micrograms per kilogram took luteinizing hormone from 4.7 to 10.7. An 11-hour infusion at 4 micrograms per kilogram per hour raised testosterone from 8.5 to 11.4 nanomoles per liter. He says healthy men showed similar increases in pulse frequency and amplitude of luteinizing hormone, with testosterone rising downstream.
Archibald explains the mechanism as working at the top of the hypothalamic pituitary gonadal axis. In his account, kisspeptin activates GnRH neurons, which drive LH and FSH release and then the body's own testosterone production. He contrasts this with outside testosterone, which he says suppresses upstream signaling, and argues that kisspeptin keeps the rhythmic, pulsatile LH pattern intact.
He is clear about limits. The study was small, with fewer than 20 participants, short-term and intravenous. He says there are no long-term randomized trials and no large safety data sets, and that nothing is approved for kisspeptin-10 as a testosterone enhancer. If someone pursues peptides, he advises working with a licensed provider and a 503A compounding pharmacy.
The last portion shifts to lifestyle. Archibald urges asking why testosterone is low in the first place, and recounts a study of young men with low testosterone who spent two weeks camping and cutting wood. He also mentions leg, back and chest training, less screen time and stress management.
On each compound
Kisspeptin-101:37
Archibald presents a 2013 intravenous study in 16 men in which he says LH more than doubled and testosterone rose with an 11-hour infusion. He describes the mechanism as GnRH neuron stimulation and stresses that the evidence is short-term, with nothing approved for testosterone enhancement.
See how your DNA reads Kisspeptin-10What this video doesn’t settle
- The video relies on one 2013 study of fewer than 20 men, so it does not show whether results hold in larger or more varied groups.
- Testosterone rose only with an 11-hour intravenous infusion, and the video does not establish any practical or sustained dosing approach.
- No long-term randomized trials or large safety data are described, so longer-term effects and risks are not addressed.
Questions this video answers
Does kisspeptin-10 increase testosterone?
Archibald cites a 2013 study of intravenous kisspeptin-10 in which testosterone rose from 8.5 to 11.4 nanomoles per liter in men with type 2 diabetes and low testosterone after an 11-hour infusion. He describes this as acute stimulation, not long-term therapy.
How does kisspeptin-10 work according to this video?
Archibald says it acts at the top of the hypothalamic pituitary gonadal axis, activating GnRH neurons that lead to LH and FSH release and then the body's own testosterone production. He says it preserves the pulsatile LH pattern.
How big was the kisspeptin-10 study Archibald discusses?
He says it was a 2013 Imperial College London study of 16 men, 10 healthy and six with type 2 diabetes and low testosterone. He calls it a small, short-term, intravenous cohort of fewer than 20 people.
Is kisspeptin-10 approved for raising testosterone?
Archibald says nothing is approved for kisspeptin-10 for testosterone enhancement. He suggests anyone interested work with a licensed medical provider using peptides from 503A compounding pharmacies.
What natural ways to raise testosterone does Archibald mention?
He describes a study in which men with low testosterone camped and cut wood for two weeks, and says their levels in some cases doubled or tripled. He also names training legs, back and chest, cutting screen time and managing stress.
Video by Regan Archibald on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
